The value of procalcitonin and brain natriuretic peptide in predicting the prognosis of sepsis.

Kaiyi Shen, Shenbei Jiang

Open access · greenAbstract read

In one paragraph

Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 45% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

Machine learning model for predicting in-hospital cardiac mortality among atrial fibrillation patients.Scientific reports · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kaiyi ShenClinical Laboratory, Deqing People's Hospital Huzhou 313200, Zhejiang, China.

Shenbei JiangClinical Laboratory, The Second Hospital of Jiaxing Jiaxing 314000, Zhejiang, China.

First Hospital of Jiaxing · CNThird People's Hospital of Huzhou · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the value of procalcitonin (PCT) and brain natriuretic peptide (BNP) in predicting the prognosis of sepsis.

methodsA total of 65 patients with sepsis received treatment in Deqing County People's Hospital from 2019 January and 2021 January and their data were collected retrospectively. Based on the survival and death of patients, 40 living patients were regarded as survival group, and 25 dead patients were regarded as the death group. PCT, BNP and, Acute Physiology and Chronic Health Evaluation II (APACHE II) scores of sepsis patients in both groups on the first, third, and seventh days of admission were collected and compared respectively. ROC curve was utilized to calculate the relationship between the three indicators and prognosis.

resultsCompared with the death group, the PCT, BNP, and APACHE II scores in the survival group were lower on the first, third, and seventh days (P < 0.05). On the first, third, and seventh day, the AUC of PCT were 0.768, 0.829, and 0.831; the AUC of BNP were 0.771, 0.805, and 0.848; the AUC of APACHE II were 0.891, 0.809, and 0.974 (P < 0.05).

conclusionThe level of plasma PCT and BNP in sepsis patients was increased, and they are positively correlated with the severity of the disease, which can be used as an indicator of bad prognosis of sepsis patients.

Indexed as

brain natriuretic peptideProcalcitoninprognosissepsis

Identifiers

PMID37056803

PMCPMC10086887

OpenAlexW4365484996

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.